Nonmyeloablative hematopoietic cell transplantation.
2001
The myeloablative doses of chemotherapy and radiation used with conventional allogeneic hematopoietic cell transplantation produce considerable morbidity and mortality that generally limit this treatment to patients younger than 55 years of age and in good general medical condition. It has become cl
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
33
Citations
NaN
KQI